dehydroretronecine has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Fu, PP; He, X; Ma, L; Xia, Q | 1 |
| Allen, JR; Hsu, IC; Robertson, KA; Shumaker, RC | 1 |
2 other study(ies) available for dehydroretronecine and Cancer of Liver
| Article | Year |
|---|---|
Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation.
Topics: Animals; Carcinogens; Cattle; Chromatography, High Pressure Liquid; DNA; DNA Adducts; Glutathione; Hep G2 Cells; Humans; Liver Neoplasms; Microsomes, Liver; Monocrotaline; Pyrrolizidine Alkaloids; Tandem Mass Spectrometry; Valine | 2018 |
Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine.
Topics: Animals; Carcinogens; Carcinoma, Hepatocellular; Injections, Subcutaneous; Liver Neoplasms; Male; Monocrotaline; Neoplasm Metastasis; Neoplasms, Experimental; Pyrrolidines; Pyrrolizidine Alkaloids; Rats; Rhabdomyosarcoma | 1976 |